immunotherapy using pollen extracts derived from one or several different Pooideae species. While for several species the most important allergens (group 1 and group 5) have been identified, other allergens have either not been identified or sequence data are still missing. We have used mass spectrometry (MS) together with genetic and immunological methods to identify allergens in various grass pollen extracts. Methods: Pollen extracts of 6 different grass species (Phleum pratense, Holcus lanatus, Lolium perenne, Dactylus glomerata, Festuca pratensis, Poa pratensis) and a mixture thereof were analyzed. For identification of allergens by MS, extracts were subjected to enzymatic digestion. Resulting peptides were separated by liquid chromatography and analyzed by tandem mass spectrometry. Protein identification was performed by searching both the NCBIPlant release and an individually designed database. The presence of individual allergens was confirmed with allergenspecific monoclonal antibodies. Unknown sequences were determined following cDNA synthesis from pollen RNA and allergen sequence amplification by PCR. Results: Fes p 1 and Fes p 5 were identified by the PCR approach. MS analysis of pollen extracts from the 6 individual species resulted in detection of all known allergens including the newly identified Fes p 1 and Fes p 5. Based on the homology of allergens from different grass species, previously unknown sequences of representatives of groups 2, 3, 4, 7, 11, 12 and 13 were detected by MS in investigated extracts with high sequence coverage. Group 6 allergens could not be identified in some of the analyzed extracts. These findings are supported by immunological analyses and thus demonstrate the specificity of the applied method. Members of all allergen groups were identified in an extract mix prepared from pollen of all 6 grass species studied. Conclusions: The most important grass allergens (group 1 and group 5) were detected in all extracts. In addition all other known allergens of the assayed species and homologues thereof could also be identified, thus demonstrating the quality of the tested extracts.
Prem Bhalla, PhD, Ruby Tiwari, PhD, and Mohan Singh, PhD. Agriculture and Food Systems, The University of Melbourne, Parkville, Australia. Background: Grass pollen allergy is one of the most common allergies worldwide. Group I allergens constitute the major allergenic component of grass pollen with more than 85% of grass pollen allergic patients showing IgE reactivity. These are highly immunologically cross-reactive glycoproteins specifically expressed in pollen of all grasses. Alignments of the amino-acid sequences of grass group I allergens derived from diverse grass species reveal up to 95% homology. It is therefore likely that these molecules share a similar biological function. Methods: RT-PCR analysis, In situ hybridisation, Promoter-GFP construct design, plant transformation and analysis of transgenic plants. Results: Sequence comparison has identified a homologue (b-expansin clone At2g20750 or EXPB1) in Arabidopsis of the Cyn d 1 gene. The EXPB1 protein is 42% similar to the Cyn d 1 protein. This gene represents a member of a small multigene family in Arabidopsis. RT-PCR analysis showed expression only in floral not vegetative tissues. In situ hybridisation using 150 bp region of the 3 9 UTR of the Arabidopsis gene as probe showed specific expression in mature Arabidopsis pollen. We further cloned the promoter region for the Arabidopsis EXPB1 and prepared and GFP fusion constructs. These constructs were then introduced in to Arabidopsis plants by floral dip method. GFP-promoter fusions showed high level of expression in tri-cellular pollen. Conclusions: Our study provides evidence that EXPB1, a non-allergenic homologue of grass group 1 pollen allergens, gene is expressed in mature pollen. Takanobashi Central Hospital, Hiroshima, Japan. Background: Allergen-specific immunotherapy (SIT) is the only promising treatment of allergy. However, current SIT has limitations such as a need for long-term medication and a risk of systemic anaphylaxis. Those issues are raised mainly because current SIT procedure is carried out using crude allergen extract, which may also induce a harmful neo-sensitization. Use of defined recombinant allergens would be a preferable alternative for the next generation SIT vaccine as well as for the development of component-resolved diagnosis (CRD), which enables to prescribe a patient-tailored vaccine. Objective of this study is to construct a production system of recombinant house dust mite (Dermatophagoides farinae) allergens, and to test their usefulness for molecular diagnosis. Methods: Thus far, the WHO/IUIS allergen nomenclature subcommittee has approved 24 Dermatophagoides allergens. Among them, we sought to express 20 groups of D. farinae allergens (Der f 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14, 15, 16, 17, 18, 20, 21, and 22) using the Escherichia coli cold shock expression system. We also tried to express additional new antigens [Mag133 (a highly-conserved UK114/YER057c/YjgF family member), DFA22 (a new group 2 family member), and DFA67 (peroxiredoxin)] that we originally identified as major allergens with high IgE-binding frequencies. IgE-binding ability of those recombinant allergens was assessed by western blot analysis. We also tested whether these allergens were applicable for the development of CRD. Results: We confirmed successful expression of above D. farinae allergen molecules as soluble recombinant proteins. Western blot analysis revealed that these recombinant allergens retained IgE-binding capacity. We also found that house dust mite-allergic patients showed differential IgE-binding signatures against them, suggesting that our recombinant allergens are useful to determine sensitized allergen molecules in individual patients. Conclusions: Here we carried out the comprehensive expression of recombinant D. farinae major allergens. The recombinant allergen repertoire offers an essential platform for the future molecular diagnostics of dust mite allergy. Background: Representatives of the family Chironomidae (non-biting midges; order Diptera) are found worldwide. Freeze-dried chironomid larvae, predominantly of the species Chironomus thummi thummi are frequently used as fish food and are an allergen source for fish keepers and persons employed in the manufacture of fish food. At present, 9 allergens of C. thummi thummi have been assigned an official designation by the WHO/IUIS allergen nomenclature sub-committee: Chi t 1 to 9. All of them are hemoglobins with molecular weights of 16 kDa. IgE binding and cross-reactivity was clearly demonstrated for all these proteins. However, the assignment of 9 distinct allergen numbers to members of the same protein family is quite unusual. Methods: Currently, the IUIS allergen database contains 12 allergen and isoallergen sequences from C. thummi thummi. The Uniprot database has demerged entry P02225, listed in the database for Chi t 7, into 7 entries, 5 from C. thummi thummi and 2 from C. thummi piger that are identical to 2 of the sequences from C. thummi thummi. Consequently, the 16 unique amino acid sequences of the mature C. thummi allergens were aligned using ClustalX2, a neighbor-joining tree was generated from the alignment and a percent sequence identity matrix was built to evaluate appropriate nomenclature. Results: Pairwise sequence alignments showed that sequences belonging to allergens Chi t 5, 6, 7 and 8 possess sequence identities to Chi t 3 of between 51 and 63%. Chi t 1, 2, 4, and 9 diverge to a greater extent from Chi t 3 (,50% identical) and from each other. Phylogenetic tree analysis suggests the clustering of Chi t 3, 6, 7, and 8, while Chi t 1, 2, 4, 5, and 9 form separate clades. Conclusions: Based on these analyses, the IUIS Allergen Nomenclature SubCommittee renames Chi t 5, 6, 7 and 8 isoallergens of Chi t 3, even though their sequence identities to Chi t 3 are below the 67% threshold previously defined for isoallergens. The remaining hemoglobins, previously designated Chi t 1, 2, 4 and 9 will retain their previous names.
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Pollen Allergens Differ From Nonallergenic Pollen Proteins by Their Lower Extent of Evolutionary Conservation
Christian Radauer, PhD, Eva Guhslc, MSc, Merima Bublin, PhD, and Heimo Breiteneder, PhD. Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria. Background: Pollen contains hundreds of different proteins. However, only a small fraction of them have been identified to be allergenic. We aimed to test the hypothesis that most pollen proteins are non-allergenic due to their high extent of sequence conservation among non-related species. Methods: Data on the composition of pollen proteomes of birch (Betula pendula), pellitory (Parientaria judaica) and timothy grass (Phleum pratense) were obtained from the literature. Sequences were downloaded from UniProt and manually classified into allergens and non-allergens. Complete proteome sequences of 3 dicotyledonous species (Arabidopsis thaliana, Populus trichocarpa and Vitis vinifera), 2 monocotyledons (Oryza sativa subsp. japonica and Zea mays) and one moss (Physcomitrella patents) were downloaded from ENSEMBL Plants. Sequences of pollen proteins were compared to these proteomes by using BLAST and the hits yielding the highest sequence identity recorded taking into account only sequence alignments at least 40 residues in length. The distributions of maximum sequence identities of allergens and non-allergens from each species were compared using the Mann-Whitney test. Results: Allergens from birch and pellitory pollen were significantly (P , 0.001) less similar to proteins from monocots than non-allergenic pollen proteins. Median sequence identities to the nearest rice and maize homologues were 49 and 52% for birch allergens, 86 and 85% for birch non-allergens, 37 and 37% for pellitory allergens, and 87 and 89% for pellitory non-allergens. Similarly, timothy grass pollen allergens were significantly (P , 0.0001) less similar to dicot proteins than non-allergenic pollen proteins. Median sequence identities to the nearest homologues were 43 to 44% for allergens and 81 to 83% for non-allergens. A comparison of all 3 pollen proteomes to sequences from the moss P. patens yielded similarly significant differences. Conclusions: Pollen allergens belong to evolutionary less conserved protein families than non-allergenic pollen proteins. The continual exposure of the human immune system to nearly identical and hence highly cross-reactive conserved proteins from multiple pollen and plant food species most likely leads to the induction of immunological tolerance rather than allergic sensitization. This study was supported by grants P-22559-B11 (to CR) and SFB-F01802 (to HB) from the Austrian Science Fund. Background: Sensitization to Betula verrucosa pollen is common in North Central Europe. In Spain, it is also common in patients from Galicia, a region located in the Northwest of Spain. Birch trees are abundant in this region and several birch species have been described. The main objectives were to determine the differences in the IgE reactivity to B. verrucosa and rBet v 1 between patients from Sweden and Spain, as well as the contribution of the major allergen Bet v 1 to the overall reactivity of B. verrucosa. Allergenicity was also compared using a serum pool derived from sera of North American (USA) patients. Methods: IgE reactivity to B. verrucosa and rBet v 1 was measured in sera from 44 Spanish and 21 Swedish patients. rBet v 1 was produced as Nterminal His-tagged fusion protein and purified as originally described. All of them were sensitized to the pollen of this tree species and suffered from allergic rhinitis during the pollination period. rBet v 1 contribution was determined by inhibition ELISA using 3 pools of sera: from Spanish, North American and Swedish patients. IgE binding pattern was evaluated by Western blots using the same pools of sera. Specific IgE binding was expressed in arbitrary units. Results: Specific IgE to B. verrucosa was detected in 50 from the 65 sera analyzed (mean ¼ 3.77 6 3.71 Units). Specific IgE levels to rBet v 1 were 3.13 6 3.32 Units. Immunoblot assays confirmed specific IgE binding to rBet v 1, and also to other allergens present in the extract. The Spanish pool presented reactivity to more allergens than the Swedish pool. ELISA Inhibition assays, performed with a native extract and rBet v 1, revealed a significant contribution (.80% inhibition) of rBet v 1 to the allergenicity of the extract, with no differences according to the origin of the sera. Conclusions: Bet v 1 has a great importance in birch allergy in Galicia and Sweden. Nevertheless, there are differences in the IgE recognition pattern according to the rest of birch allergens. Mayor allergen from birch, Bet v 1, significantly contributes to the allergenicity of B. verrucosa in Galicia. Allergen Research, Allergopharma Joachim Ganzer KG, Reinbek, Germany. Background: The prevalence of sensitization to ragweed has risen in North America and across Europe. Although the pectate lyase Amb a 1, the major allergen of ragweed, was identified as long ago as the 1960s, little is known about the allergenicity of the 5 Amb a 1 isoallergens and other allergens present in ragweed pollen. Ragweed extracts and purified Amb a 1 isoallergens have now been characterized for their allergenic potential to determine whether a single Amb a 1 isoallergen, several isoallergens or a combination with other allergens should be included in a recombinant SIT vaccine.
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